← k3vl4r
Log inGet started →

GH (Guardant Health Inc) Price Forecast

AI-generated price forecast for Guardant Health Inc (GH) across 1-hour, 4-hour, daily and weekly horizons — updated continuously, with a public accuracy track record.

The desk streams live daily· see the schedule →

As of September 2026: K3vl4r's AI model currently reads GH as 2/2 bearish · strong across its horizons (0 of 2 timeframes pointing up), with a last price of 162.50. See our public, auditable track record →

📈 Daily Top Picks beating the S&P 500 since launch→✓ Public, verifiable track record Live system status💎 Get the full AI report · pay with XRP

Last price

162.50

AI outlook

2/2 bearish · STRONG

Timeframes up

0 / 2

Share𝕏PostTelegram

GH forecast by horizon

HorizonDirectionProjected move (end of horizon)Bullish prob.
1-hour———
4-hour~4 weeks out———
Daily~4 months out▼ Down-57.53%0%
Weekly~1.8 years out▼ Down-62.18%—

Latest GH news

From the market-news feed the forecasts are read against.

  • Guardant Health Faces a $245 Million Patent Judgment, But Its Newer Tests Could Offer Protection · Insider Monkey · Sep 4
  • BTIG Reiterates Buy on Guardant Health, Maintains $195 Price Target · Benzinga · Sep 2
  • Guardant Health’s Shield Blood Test Covered by Carelon Health Services for Colorectal Cancer Screening · Yahoo · Sep 1
  • Carelon Health Services To Cover Guardant Health’s Shield Blood Test · Benzinga · Sep 1
  • Guardant Health (GH) Stock Could Trade At A 21% Discount Despite Patent Appeal · Simply Wall St. · Aug 27

🔒

See the full GH forecast

Interactive forecast chart, price targets, and Monte-Carlo confidence bands — plus the daily AI Top Picks book. Free to start, no card required.

Create a free account →

Already have one? Log in

GH forecast — frequently asked

Will GH go up?

K3vl4r's AI model currently reads GH as 2/2 bearish · STRONG — 0 of 2 forecast horizons point up, so the overall read is leaning to the downside. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

What is the GH price prediction for 2026?

K3vl4r's model projects GH toward $160.48 over the next ~4 months, a -0.6% move from $161.41. Projections update continuously as new data arrives and are inherently uncertain. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

What price could GH reach?

Over its longest horizon (~~1.8 years), the model's projected target for GH is $160.41 (-0.6% vs $161.41). Confidence decreases the further out the horizon, so treat longer-range targets as one scenario, not a guarantee. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

Part of Healthcare forecasts — browse the full sector.

More AI forecasts

CMPXIMNMRGNXARVNSHCEQAVTXIFRXBGMSCTXRSPRYSTOKQNTMMNKD

Will GH reach…?

Will GH reach $200.00?Will GH reach $250.00?Will GH reach $500.00?Will GH reach $1,000?

Or see the full GH price prediction (2027–2040), or the forecast for today, tomorrow and this week.

Compare GH

GH vs CMPXGH vs IMNMGH vs RGNXGH vs ARVNGH vs SHCGH vs EQ

Curious how this is generated? Read how K3vl4r forecasts — the model, the confidence bands, and what we deliberately do not claim.

K3vl4r publishes a public, auditable track record of its Daily Top Picks — see the live results.

Forecasts are model-generated estimates for informational purposes only and are not financial advice. Markets are risky; past accuracy does not guarantee future results. See our Risk Disclosure.

StreamWatch on Kick·Watch on YouTube
k3vl4rTop PicksTrack recordChart indicatorsToday's outlookStream scheduleBiggest moversMarket heatmapForecasts by sectorAI reportsMarket videosCompareMethodologyBest AI toolsAboutFAQ◈ KVLHow KVL worksTokenomicsPricingX (Twitter)YouTube — daily showsTikTokTwitch — live forecastingDiscord community

Join the community on Discord and catch the desk stream live on Kick or YouTube. Create a free account →

Forecasts are AI-generated; written analysis is AI-assisted and human-reviewed. Informational only, not financial advice. See Terms, Risk Disclosure, Privacy · Methodology · Status.